Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

English Pharmaceutical Industries

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx111product presentations
G46generic molecules
DF6dosage-form groups
TA4therapeutic areas
PKR111current price records
REG102registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage96%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified95 products · 86%
Third-generation cephalosporins7 products · 6%
Fluoroquinolone antibacterials4 products · 4%
Proton pump inhibitors3 products · 3%
HMG-CoA reductase inhibitors2 products · 2%
Formulation footprint

Dosage forms

Injection59 products
Tablet24 products
Capsule12 products
Suspension9 products
Syrup5 products
Infusion2 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2323% of comparable products
Near market median52within ±5% of median
Above market median2626% of comparable products
Lowest-price equivalents11ties included
Company median price position 0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Regulatory & price activity

Observed database signals

Registration numbers102
Price-history records117
Products with price history6
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date27 Jul 2026
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

111 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Cipronag Ciprofloxacin 200 mg IV infusion 100ml 040136 PKR 242.78 PKR 2.43/mL 15% above median
Cipronag Ciprofloxacin 500 mg Tablet 10's 029015 PKR 526.03 PKR 52.60/tablet 25% above median
Colaite Colistimethate sodium 1 MIU IV injection 1's 092529 PKR 1,199.81 PKR 1,199.81/vial/unit Near median
Coliate Colistimethate sodium 4.5 MIU (≈150 mg colistin base activity) Injection 1's 116494 PKR 4,501.60 PKR 4,501.60/vial/unit Near median
Coliate Colistimethate sodium 2 MIU (≈68 mg colistin base activity) Injection 1's 115682 PKR 2,000.07 PKR 2,000.07/vial/unit Near median
E-Cip Ciprofloxacin 250 mg Capsule 10's 059760 PKR 263.01 PKR 26.30/capsule Near median
E-Cip Ciprofloxacin 250 mg/5 mL Suspension 60ml 067993 PKR 323.71 PKR 5.40/mL 6% above median
E-Cip Ciprofloxacin 125 mg/5 mL Suspension 60ml 067988 PKR 182.09 PKR 3.03/mL 14% below median
E-Cip Ciprofloxacin 500 mg Capsule 10's 059759 PKR 434.99 PKR 43.50/capsule 5% above median
E-Lev Levofloxacin 500 mg Capsule 10's 059762 PKR 667.65 PKR 66.77/capsule Near median
E-Lev Levofloxacin 250 mg Capsule 10's 059761 PKR 404.64 PKR 40.46/capsule Near median
Eaxiron Cefotaxime 0.25 g Injection Vial 032130 PKR 104.38 PKR 104.38/vial/unit Near median
Eaxiron Cefotaxime 1 g Injection Vial 032132 PKR 282.94 PKR 282.94/vial/unit Near median
Eaxiron Cefotaxime 0.5 g Injection Vial 032131 PKR 160.61 PKR 160.61/vial/unit Near median
Ekacin Amikacin 50 mg Injection 1's 047843 PKR 47.61 PKR 47.61/vial/unit Near median
Ekacin Amikacin 500 mg Injection 2mlx1's 046407 PKR 238.07 PKR 119.04/mL Near median
Ekacin Amikacin 100 mg Injection 2mlx1's 046408 PKR 78.09 PKR 39.05/mL Near median
Ekacin Amikacin 250 mg Injection 2mlx1's 046406 PKR 130.53 PKR 65.27/mL Near median
Eloglipten Metformin 500 mg Tablet 50's 086288 PKR 98.82 PKR 1.98/tablet 26% below median
Encogyl Metronidazole (Benzoate) 500 mg Injection Vial 038370 PKR 127.61 PKR 127.61/vial/unit No comparator
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.